Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 185 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies

Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia, Follicular Lymphoma Brazil

Iptacopan in Patients With ANCA Associated Vasculitis

Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis Phase2 Argentina
Australia
Austria
Belgium
Canada
China
Czechia
Denmark
France
Germany
Hungary
Netherlands
Spain
Turkey (Türkiye)
United Kingdom
United States
View All

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

Prostate Cancer Phase4 Austria
Belgium
Canada
Czechia
France
Germany
Netherlands
Spain
Sweden
United Kingdom
United States
View All

A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia

Warm Autoimmune Hemolytic Anemia (wAIHA) Phase3 Argentina
Australia
China
France
Germany
Israel
Italy
Japan
Spain
United Kingdom
United States
View All

Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)

Primary Immune Thrombocytopenia (ITP) Phase3 Argentina
Australia
Belgium
China
Czechia
France
Germany
Malaysia
Singapore
Spain
United Kingdom
United States
View All

Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer Phase1 Germany
Japan
South Korea
Spain
Switzerland
United States
View All

Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)

Polymyalgia Rheumatica Phase3 Argentina
Australia
Belgium
Brazil
Canada
Chile
Colombia
Czechia
Denmark
France
Germany
Hungary
Israel
Italy
Japan
Mexico
Netherlands
Poland
South Africa
Spain
Switzerland
United Kingdom
United States
View All

Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in France

Breast Cancer France

Revolade Tablets Specified Drug-use Survey

Aplastic Anemia Japan

Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases

Myeloid Diseases Phase1 France
Germany
Hong Kong
Italy
Singapore
Spain
United Kingdom
United States
View All